Causal associations between atrial fibrillation and breast cancer: A bidirectional Mendelian randomization analysis
- PMID: 38468558
- PMCID: PMC10928448
- DOI: 10.1002/cam4.7067
Causal associations between atrial fibrillation and breast cancer: A bidirectional Mendelian randomization analysis
Abstract
Background: Previous observational studies indicated that atrial fibrillation may increase the risk of breast cancer. Following a breast cancer diagnosis, the chance of developing atrial fibrillation may increase as well. However, it is uncertain whether the link is causal or just due to confounding factors.
Objective: Using bidirectional Mendelian randomization (MR) analysis, we sought to assess the bidirectional causal relationship between atrial fibrillation and breast cancer from a genetic level.
Methods: Large genome-wide association studies yielded summary-level data for atrial fibrillation and breast cancer. The preliminary estimate was inverse variance weighted (IVW) under a random model. MR-Egger, weighted median, simple mode, weighted mode, and multivariable MR (adjusting body mass index, smoking, and alcohol drinking) were performed as sensitivity analyses.
Results: Genetically predicted atrial fibrillation presented no statistically significant association with overall breast cancer (odds ratio [OR] = 1.00; 95% confidence interval [CI]: 0.97-1.04; p = 0.79), estrogen receptor (ER) + (OR = 1.00; 95% CI: 0.96-1.03; p = 0.89) or ER- subtypes (OR = 1.00; 95% CI: 0.97-1.04; p = 0.89). Similarly, genetically predicted overall breast cancer (OR = 1.01; 95% CI: 0.98-1.04; p = 0.37), ER+ (OR = 1.02; 95% CI: 0.99-1.05; p = 0.16) or ER- (OR = 0.98; 95% CI: 0.93-1.02; p = 0.32) subtypes had no causal effect on atrial fibrillation. Sensitivity analyses yielded similar results. Individual single nucleotide polymorphism had little effect on the total estimate. We did not observe any evidence of horizontal pleiotropy.
Conclusions: Our bidirectional MR studies revealed that there may be no causal links between atrial fibrillation and breast cancer.
Keywords: Mendelian randomization; atrial fibrillation; breast cancer; causal association.
© 2024 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
All authors declared no conflicts of interest.
Figures



Similar articles
-
Assessing the causal associations of atrial fibrillation with serum uric acid level and gout: insights from a bidirectional mendelian randomization study.BMC Cardiovasc Disord. 2024 Nov 13;24(1):638. doi: 10.1186/s12872-024-04319-7. BMC Cardiovasc Disord. 2024. PMID: 39538126 Free PMC article.
-
Causal Effect of Obstructive Sleep Apnea on Atrial Fibrillation: A Mendelian Randomization Study.J Am Heart Assoc. 2021 Dec 7;10(23):e022560. doi: 10.1161/JAHA.121.022560. Epub 2021 Nov 19. J Am Heart Assoc. 2021. PMID: 34796736 Free PMC article.
-
No association between alcohol consumption and risk of atrial fibrillation: A two-sample Mendelian randomization study.Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1389-1396. doi: 10.1016/j.numecd.2020.04.014. Epub 2020 Apr 24. Nutr Metab Cardiovasc Dis. 2020. PMID: 32540331
-
Causal effects between atrial fibrillation and heart failure: evidence from a bidirectional Mendelian randomization study.BMC Med Genomics. 2023 Aug 14;16(1):187. doi: 10.1186/s12920-023-01606-8. BMC Med Genomics. 2023. PMID: 37580781 Free PMC article.
-
Genetically predicted childhood obesity and adult atrial fibrillation: A mendelian randomization study.Nutr Metab Cardiovasc Dis. 2022 Apr;32(4):1019-1026. doi: 10.1016/j.numecd.2021.12.001. Epub 2021 Dec 4. Nutr Metab Cardiovasc Dis. 2022. PMID: 35086764
Cited by
-
Screening and Risk Analysis of Atrial Fibrillation After Radiotherapy for Breast Cancer: Protocol for the Cross-Sectional Cohort Study "Watch Your Heart (WATCH)".JMIR Res Protoc. 2025 Jun 4;14:e67875. doi: 10.2196/67875. JMIR Res Protoc. 2025. PMID: 40466092 Free PMC article.
-
Bidirectional two-sample Mendelian randomization study of atrial fibrillation and breast cancer.Front Cardiovasc Med. 2024 Nov 25;11:1434963. doi: 10.3389/fcvm.2024.1434963. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39654951 Free PMC article.
References
-
- Hindricks G, Potpara T, Dagres N, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio‐Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373‐498. - PubMed
-
- Marijon E, Le Heuzey JY, Connolly S, et al. Causes of death and influencing factors in patients with atrial fibrillation: a competing‐risk analysis from the randomized evaluation of long‐term anticoagulant therapy study. Circulation. 2013;128(20):2192‐2201. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical